Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Vinorelbine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 7 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Hodgkin Disease 4 Recurrence 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma 2 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 NSCLC 1 Mesothelioma, Malignant 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 HR+HER2- Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡